NEW YORK (GenomeWeb) – Hologic said today that it expects to report revenues for its first fiscal quarter of about $791 million, an almost 8 percent year-over-year rise from Q1 2017.

The company had guided for revenues in the range of $775 million to $790 million.

For Q1 ended Dec. 30, the firm's diagnostics business revenues are expected to drop to $285 million from $325 million in the prior-year quarter. When the firm's diagnostics products revenues exclude sales from its blood business, revenues are expected to rise to $272 million from $260 million in Q1 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.